a) DS AMKL vs. non-DS AMKL | |||||
Chr and location a | Segment start b | Segment end b | 'A'/'B' ratio | q-value | Genes in the segment c |
Over-expressed segments | |||||
chr15 15q21.2 | 50,250,001 | 50,750,000 | 3.27 | 0.00233 | ATP8B4- SLC27A2+ HDC+ GABPB1+ FLJ10038+ GABPB1-AS1+ Hs.656448+ Hs.660869+ d USP8+ |
chr4 4q31.1 | 144,750,001 | 145,250,000 | 2.21 | 0.00024 | GYPE+ Hs.658686- GYPB + GYPA + |
chr19 19q13.2 | 45,000,001 | 45,500,000 | 1.58 | 0.00461 | ZNF180- PVR+ CEACAM19- BCL3+ CBLC+ BCAM+ PVRL2- Hs.666142- TOMM40+ APOE+ APOC1 + APOC4+ APOC2 + CLPTM1+ |
b) DS AMKL vs. MK | |||||
Chr and location | Segment start | Segment end | 'A'/'D' ratio | q-value | Genes in the segment |
Over-expressed segments | Â | Â | Â | Â | Â |
chr3 p26.2 | 3,500,001 | 4,000,000 | 20.81 | 0.00006 | Hs.241414+ Hs.587205+ LRRN1 + Hs.128128+ |
chr1 1q23 | 166,000,001 | 166,500,000 | 18.07 | 0.00004 | Hs.22930+ FAM78B+ Hs.662048+ |
chr15 15q26.2 | 96,750,001 | 97,250,000 | 14.73 | 0.00001 | Hs.677040+ Hs.661950+ NR2F2-AS1 + NR2F2- Hs.592015+ |
Under-expressed segments | |||||
chr4 4q12-q21 | 74,750,001 | 75,250,000 | 0.45 | 0.00079 | PF4 - PPBP - CXCL5- CXCL3 - CXCL2- MTHFD2L- Hs.662627- EREG- |
chr4 4q32.1 | 156,250,001 | 156,750,000 | 0.13 | 0.00012 | MAP9- GUCY1A3 - Hs.612374- GUCY1B3 - |
c) Non-DS AMKL vs. MK | |||||
Chr and location | Segment start | Segment end | 'B'/'D' ratio | q-value | Genes in the segment |
Over-expressed segments | |||||
chr15 15q26.2 | 96,750,001 | 97,250,000 | 22.30 | <0.00001 | Hs.677040+ Hs.661950+ NR2F2-AS1 + NR2F2- Hs.592015+ |
Under-expressed segments | |||||
chr4 4q13-q21 | 74,500,001 | 75,000,000 | 0.39 | 0.00009 | IL8- CXCL6- PF4V1 - CXCL1- PF4 - PPBP - CXCL5- CXCL3 - CXCL2- |